Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · page 8 of 26
Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.
Pitch deck · market_sizing · size_opportunity · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
callout 2/2 disclaimer 1/1 metric 3/3 table 2/2 title 1/1
Components 9
primary primary disclaimer big-number big-number big-number data data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.